摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-环丙基-5-硝基-6,7,8-三氟-1,4-二氢-4-氧代-3-喹啉羧酸乙酯 | 103772-12-9

中文名称
1-环丙基-5-硝基-6,7,8-三氟-1,4-二氢-4-氧代-3-喹啉羧酸乙酯
中文别名
——
英文名称
ethyl 1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-5-nitro-4-oxo-3-quinolinecarboxylate
英文别名
5-nitro-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester;Ethyl 1-cyclopropyl-6,7,8-trifluoro-5-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate;ethyl 1-cyclopropyl-6,7,8-trifluoro-5-nitro-4-oxoquinoline-3-carboxylate
1-环丙基-5-硝基-6,7,8-三氟-1,4-二氢-4-氧代-3-喹啉羧酸乙酯化学式
CAS
103772-12-9
化学式
C15H11F3N2O5
mdl
——
分子量
356.258
InChiKey
PRNXYRWUZSNSFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    511.3±50.0 °C(Predicted)
  • 密度:
    1.615±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    92.4
  • 氢给体数:
    0
  • 氢受体数:
    9

安全信息

  • 海关编码:
    2933499090

SDS

SDS:f392b275e0d379340a7dd4b249acb80c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    1-环丙基-5-酰胺-6,7,8-三氟-1,4-二氢-4-氧代-3-喹啉羧酸乙酯 ethyl 5-amino-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 103772-13-0 C15H13F3N2O3 326.275
    5-氨基-1-环丙基-6,7,8-三氟-4-氧代-1,4-二氢-3-喹啉羧酸 5-Amino-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 103772-14-1 C13H9F3N2O3 298.221
    —— 1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-5-(methylamino)-4-oxo-3-quinolinecarboxylic acid 114373-09-0 C14H11F3N2O3 312.248
    —— 1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-5-[(trifluoroacetyl)amino]-3-quinolinecarboxylic acid 115904-56-8 C15H8F6N2O4 394.23
    —— 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid 110236-78-7 C17H18F2N4O3 364.352
    —— 5-Amino-1-cyclopropyl-6,8-difluoro-7-[(3-ethylamino-methyl)-1-pyrrolidinyl]-1,4-dihydro-4-oxo-3quinolinecarboxylic Acid 103784-28-7 C20H24F2N4O3 406.432
    —— 5-amino-1-cyclopropyl-6,8-difluoro-7-(4-methyl-1-piperazinyl)-4(1H)-oxoquinoline-3-carboxylic acid 110236-79-8 C18H20F2N4O3 378.379
    —— 5-amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 112654-98-5 C17H18F2N4O3 364.352
    司氟沙星 5-amino-1-cyclopropyl-7-(3,5-dimethyl-piperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid 111542-93-9 C19H22F2N4O3 392.405
    —— 5-amino-1-cyclopropyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 110871-85-7 C18H20F2N4O3 378.379

反应信息

  • 作为反应物:
    参考文献:
    名称:
    4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial
    摘要:
    描述了新型萘啉基、喹啉基和苯并噁嗪羧酸作为抗菌剂的小说,以及它们的制造、配方和用于治疗细菌感染的方法,包括用于制造抗菌剂的某些新型中间体的描述。
    公开号:
    US04822801A1
  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship
    摘要:
    A series of 5-amino- and 5-hydroxyquinolone antibacterials substituted at C7 with a select group of common piperazinyl and 3-aminopyrrolidinyl side chains was prepared. These 5-substituted derivatives were compared to the analogous 5-hydrogen compounds for antiinfective activity by using DNA gyrase inhibition, minimum inhibitory concentrations against a variety of bacteria, and in vivo efficacy in the mouse infection model. The influence on the structure-activity relationships of varied substituents at C8 (H, F, Cl) and Ni (ethyl, cyclopropyl, difluorophenyl) was also studied. The results showed that several of the structure-activity conclusions regarding side-chain bulk at C7, the effect of halogen at C8, and the effect of the C5-amino group were greatly influenced by the choice of the N1-substituent. Several outstanding broad spectrum quinolones were identified in this work. In particular, the spectrum and potency of the 7-piperazinyl quinolones could be greatly enhanced by the judicious choice of C5-, C8-, and N1-substitutents.
    DOI:
    10.1021/jm00107a039
点击查看最新优质反应信息

文献信息

  • 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial
    申请人:Warner-Lambert Company
    公开号:US04822801A1
    公开(公告)日:1989-04-18
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    描述了新型萘啉基、喹啉基和苯并噁嗪羧酸作为抗菌剂的小说,以及它们的制造、配方和用于治疗细菌感染的方法,包括用于制造抗菌剂的某些新型中间体的描述。
  • Antibacterial agents - II
    申请人:Warner-Lambert Company
    公开号:US05097032A1
    公开(公告)日:1992-03-17
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    本文描述了新型萘啶、喹啉和苯并噁嗪羧酸作为抗菌剂,以及其制备、配方和治疗细菌感染的使用方法,包括制备抗菌剂所使用的某些新型中间体的描述。
  • Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0172651A1
    公开(公告)日:1986-02-26
    Novel naphthyridine-, quinoline- and benzoxazine carboxylic acids of formula or as antibacterial agents are described as well as methods for their manufacture and formulation. Also disclosed are certain novel intermediates used in the manufacture of the antibacterial agents.
    描述了新颖的式或作为抗菌剂的萘啶、喹啉和苯并噁嗪羧酸及其制造和配制方法。 此外,还公开了用于制造抗菌剂的某些新型中间体。
  • Substituted-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids, derivatives thereof, pharmaceutical compositions comprising the compounds, and processes for producing the compounds
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0265230A1
    公开(公告)日:1988-04-27
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids of formula in which Z is are disclosed. The compounds are useful as antibacterial agents. Also disclosed is a process for producing the compounds and a pharmaceutical composition comprising the compounds.
    新颖的萘啶、喹啉和苯并噁嗪羧酸,其式为 其中 Z 为 的新型萘啶-喹啉-和苯并噁嗪羧酸。这些化合物可用作抗菌剂。还公开了生产这些化合物的工艺和包含这些化合物的药物组合物。
  • 5-Amino and 5-hydroxy-6,8-difluoroquinolones as antibacterial agents
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0226961B1
    公开(公告)日:1991-06-12
查看更多